Nasty to watch huh, but try and remember how backlogged the labs have been, do your nerves a favour and ring the company and see if thier is results in the pipeline.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
